For Immediate Release
ST. GEORGE, UT — August 3, 2026 — An honest, physician-written look at stem cell therapy for knee pain: what the research actually shows, realistic outcomes, risks, and how to avoid predatory clinics.
Some smaller clinical trials report pain reduction and functional improvement for a subset of patients with mild-to-moderate osteoarthritis, generally lasting months rather than years. There is no strong, reproducible human evidence that these injections regenerate clinically meaningful amounts of cartilage.
Warning signs include guaranteed results, claims of cartilage regrowth or a cure, pressure to book same-day, and vague answers about FDA approval status. A reputable provider will discuss the investigational nature of treatment openly.
Chronic pain often involves nervous system sensitization that amplifies pain signals beyond what tissue damage alone would predict. Addressing the nervous system alongside any medical treatment can meaningfully change how pain is experienced.
“Recovery is possible with the right, evidence-based support — that is the work we do every day at The Bridge.” — Dr. Daren Brooks, D.O., Founder & CEO, The Bridge Health Recovery Center
Read the full guide: Stem Cell Therapy for Knee Pain: What to Realistically Expect.
Author: Dr. Daren Brooks, D.O., Founder & CEO, The Bridge Health Recovery Center